Stellantis STLA Stock Analysis 088 Loss Key Levels 20260519 Saratoga SAZ Q1 2026 Results Fall Short EPS 016 Revenue NA Jefferies JEF Holds 5185 Direction Awaited 20260518 Vladimir Guerrero Jrs TwoWord Endorsement Signals Confidence in Blue Jays New Offensive Addition Rezolute RZLT Gained 355 Can It Break 337 20260520 SPS Commerce SPSC Holds Steady Near Support Amid Modest Decline Starbucks Korea CEO Removed Amid Controversial Tank Day Tumbler Promotion Fallout HAE Q1 2026 Earnings EPS Slightly Tops Estimates Stock Advances 4 SK Hynix Surpasses 1 Trillion Market Cap Amid AIDriven Surge in Chip Stocks Burberry Shares Surge on Takeover Speculation Following Moncler Bid Report X Faces Regulatory Penalty in Australia Over Child Safety Compliance Indias Parody Cockroach Party Claims Website Blocked Amid Digital Content Scrutiny Taiwan Stock Exchange Eyes Extended Trading Hours and OddLot Reforms to Boost Market Competitiveness Traders Bet on 16 Nifty Swing with Long Straddle Amid West Asia Tensions GPI Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick Fox Factory Holding Corp FOXF Q1 2026 Earnings EPS Surges Past Estimates as Cost Cuts Take Hold TEO Q1 2026 Earnings Massive EPS Surprise But Modest Market Reaction Air Lease Corporation AL Q4 2025 Earnings Strong EPS Beat Driven by Portfolio Management and Lease Rate Momentum Modular Medical Inc MODD Q3 2025 Earnings Narrowed Loss Per Share Despite Surprise Miss Stock Rises 458 Europes Digital Sovereignty at Risk Telecom Executive Warns of US Dominance in Satellites and AI European Household Energy Costs Show Divergent Trends Amid Geopolitical Tensions MDRR Q2 2021 Earnings EPS Surprises Positive but Stock Unchanged Deutsche Bank DB Q1 2026 Earnings Modest EPS Beat as Investment Banking Revenue Holds Steady Bharti Airtel Deepens Overseas Push with Increased Stakes in Africa and UKs BT Group CaliberCos Inc CWD Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Market Microsoft Signals Potential 190 Billion Capital Spending by 2026 Amid Rising Memory Costs NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43